Research Article

A Triple-Blinded Randomized Study to Evaluate the Effect of Acetaminophen and Morphine Sulfate on Pain Relief in MI-patients

Abstract

Background: Myocardial infarction is considered to be the most common symptom of cardiovascular diseases. Regarding the limitation of access to Morphine sulphate as a special drug and complications followed, this study aims to compare the treatment effects of intravenous acetaminophen and morphine sulphate on the reduction of pain in MI patients and to improve the cardiac performance.
Methods: The present study is a triple-blind randomized control trial in which 70 patients were divided into two separated groups and the pain was measured using Visual Analogue Scale. All analysis was done using SPSS Software at the significance level of 5 percent.
Results: 42 patients were male (60%) of whom 20 were in case group and 22 in control group. There were no significant difference between intervention group and control group in terms of VAS score (p = 0.520). The index change of VAS over the time was statistically significant (p=0.001) in intervention and control groups (intra group change). The results of variance analysis with repeated measurements showed that mean differences of Ejection Fraction over time in both groups of intervention and control was not statistically significant (p=0.28).
Conclusion: The findings of this study demonstrate that although Acetaminophen does not have an improved effect on pain control and cardiac performance than Morphine sulphate, it can be still an appropriate alternative for Morphine sulfate due to the lack of destructive effects and its availability.

[1] Guilbert JJ. The world health report 2002 - reducing risks, promoting healthy life. Educ Health (Abingdon). 2003;16(2):230.
[2] Khalili D, Mosavi-Jarrahi A, Eskandari F, Mousavi-Jarrahi Y, Hadaegh F, Mohagheghi M, et al. Evaluation of cause of deaths' validity using outcome measures from a prospective, population based cohort study in Tehran, Iran. PLoS One. 2012; 7:e31427.
[3] Hadaegh F, Harati H, Ghanbarian A, Azizi F. Prevalence of coronary heart disease among Tehran adults: Tehran lipid and glucose study. East Mediterr Health J. 2009; 15(1):157-66.
[4] Smeltzer SC, Bare BG. Brunner and Suddarth’s Text book of Medical-surgical Nursing. 9th ed: Philadelphia; 2008.
[5] Asgari MR, Soleimani M. Comprehensive book Intensive nursing cares in CCU, ICU, and Dialysis wards. 12th ed. Tehran: Boshra; 2012.
[6] Hale SL, Kloner RA. Acetaminophen and experimental acute myocardial infarction. Cardiovasc Drugs Ther. 2004; 18:121-5.
[7] Leshnower BG, Sakamoto H, Zeeshan A, Parish LM, Hinmon R, Plappert T, et al. Role of acetaminophen in acute myocardial infarction. Am J Physiol Heart Circ Physiol. 2006; 290(6):H2424-H31.
[8] Golfetti R, VanDyke K, Rork T, Spiler N, Merrill G. Acetaminophen in the post-ischemia reperfused myocardium. Exp Biol Med (Maywood). 2002; 227(11):1031-7.
[9] Merrill G, McConnell P, Vandyke K, Powell S. Coronary and myocardial effects of acetaminophen: protection during ischemia-reperfusion. Am J Physiol Heart Circ Physiol. 2001; 280:H2631-H8.
[10] Coker SJ, Parratt JR, Ledingham IM, Zeitlin IJ. Thromboxane and prostacyclin release from ischaemic myocardium in relation to arrhythmias. Nature. 1981; 291(5813):323-4.
[11] Fulton RL, Walters MR, Morton R, Touyz RM, Dominiczak AF, Morrison DS, et al. Acetaminophen use and risk of myocardial infarction and stroke in a hypertensive cohort. Hypertension. 2015; 65(5):1008-14.
[12] Gorman I. Acetaminophen safe to use after heart attack but not protective. Am J Physiol heart. 2006; 227:1.
[13] Merrill GF. Acetaminophen and low-flow myocardial ischemia: efficacy and antioxidant mechanisms. Am J Physiol Heart Circ Physiol. 2002;282(4):H1341-H9.
[14] Honorio T, Raj’s B. practical management of pain. 4th ed: Mosby Elsevier; 2008.
[15] Ghalamghash R, Goosheh B, Emrani A, Keyhani MR, Hosseini A. Effect of cardiac rehabilitation program on functional capacity following valvular heart surgery. JCRP. 2007; 27(5):346.
[16] Rosenberg L, Rao RS, Palmer JR. A case-control study of acetaminophen use in relation to the risk of first myocardial infarction in men. Pharmacoepidemiol Drug Saf. 2003; 12(6):459-65.
[17] Charpentier S, Galinski M, Bounes V, Ricard-Hibon A, Khoury CE, Elbaz M, et al. Analgesia with nitrous oxide/oxygen and acetaminophen compared to morphine analgesia in patients with acute myocardial infarction: Results from the SCADOL II clinical trial. Arch Cardiovasc Dis Suppl. 2019; 11:e300.
[18] ABDI A, Basgut B. An evidence-based review of pain management in acute myocardial infarction. J Cardiol Clin Res. 2016;4(4):1067.
[19] Graham GG, Davies MJ, Day RO, Mohamudally A, Scott KF. The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings. Inflammopharmacology. 2013; 21:201-32.
[20] Sin B, Wai M, Tatunchak T, Motov SM. The use of intravenous acetaminophen for acute pain in the emergency department. Acad Emerg Med. 2016; 23:543-53.
[21] Merrill GF, Rork TH, Spiler NM, Golfetti R. Acetaminophen and myocardial infarction in dogs. Am J Physiol Heart Circ Physiol. 2004; 287(5):H1913-H20.
Files
IssueVol 7 No 2 (2021): Spring QRcode
SectionResearch Article(s)
DOI https://doi.org/10.18502/aacc.v7i2.6297
Keywords
Myocardial Infarction Analgesia Morphine Intravenous Acetaminophen
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Bakhshaei MH, Homayounfar S, Roozbahani B, Malekpour M, Farhadian M. A Triple-Blinded Randomized Study to Evaluate the Effect of Acetaminophen and Morphine Sulfate on Pain Relief in MI-patients. Arch Anesth & Crit Care. 2021;7(2):63-68.